Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
Public ClinicalTrials.gov record NCT01684761. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether Tcelna (imilecleucel-T, autologous T-Cell Immunotherapy) is effective in the treatment of secondary progressive multiple sclerosis (SPMS).
Study identification
- NCT ID
- NCT01684761
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 183 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2012 (Type not available)
- Primary completion
- Oct 2016 (Actual)
- Completion
- Oct 2016 (Actual)
- Last update posted
- Jan 10, 2017
2012 – 2016
United States locations
- U.S. sites
- 33
- U.S. states
- 18
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| HOPE Research Institute | Phoenix | Arizona | 85050 | — |
| Northwest NeuroSpecialists, LLC | Tucson | Arizona | 85741 | — |
| Alta Bates Summit Medical Center, The Research and Education Development Institute | Berkeley | California | 94705 | — |
| Neurology Associates, P.A. | Maitland | Florida | 32751 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Collier Neurologic Specialists, LLC | Naples | Florida | 34102 | — |
| Neurological Services of Orlando | Orlando | Florida | 32806 | — |
| Meridien Research | Tampa | Florida | 33606 | — |
| Vero Beach Neurology | Vero Beach | Florida | 32960 | — |
| Shepherd Center | Atlanta | Georgia | 30309 | — |
| Consultants In Neurology, Ltd. | Northbrook | Illinois | 60062 | — |
| Fort Wayne Neurological Center | Fort Wayne | Indiana | 46804 | — |
| Josephson Wallack Munshower Neurology, PC | Indianapolis | Indiana | 46256 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Associates in Neurology | Lexington | Kentucky | 40503 | — |
| Saint Elizabeth's Medical Center | Boston | Massachusetts | 02135 | — |
| Island Neurological Assoicates, PC | Plainview | New York | 11803 | — |
| University Hospital and Medical Center Stony Brook New York | Stony Brook | New York | 11794-8121 | — |
| The Neurological Institute, PA | Charlotte | North Carolina | 28204 | — |
| Carolinas Medical Center Neurology | Charlotte | North Carolina | 28207 | — |
| PMG Research of Charlotte | Charlotte | North Carolina | 28209 | — |
| Neurology Specialists, Inc | Dayton | Ohio | 45408 | — |
| Providence Medical Group - Medford | Medford | Oregon | 97504 | — |
| Providence St. Vincent Medical Center - Northwest MS Center | Portland | Oregon | 97225 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| The Maxine Mesinger MS Clinic/Baylor College of Medicine | Houston | Texas | 77030 | — |
| Central Texas Neurology | Round Rock | Texas | 78681 | — |
| Integra Clinical Research, LLC | San Antonio | Texas | 78229 | — |
| Fletcher Allen Health Care - Neurology Service | Burlington | Vermont | 05401 | — |
| Hampton Roads Neurology | Newport News | Virginia | 23601 | — |
| Neurological Associates, Inc | Richmond | Virginia | 23226 | — |
| Swedish Neuroscience Institute | Issaquah | Washington | 98029 | — |
| Swedish Neuroscience Institute | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01684761, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 10, 2017 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01684761 live on ClinicalTrials.gov.